This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Alexander U Kotov: Innovator in Immunomodulatory Compounds
Introduction
Alexander U Kotov is a notable inventor based in St. Petersburg, Russia. He has made significant contributions to the field of immunology through his innovative work on synthetic immunomodulatory molecules. His research focuses on compounds that can enhance the immune response, which is crucial for developing new therapeutic strategies.
Latest Patents
Kotov holds a patent for a new class of synthetic immunomodulatory molecules, specifically those containing a .gamma.-L-glutamyl moiety at the amino terminus. His patent, titled ".gamma.-L-glutamyl containing immunomodulator compounds and methods," introduces various compounds, including Bestim, .gamma.-L-glutamyl-L-tryptophan, and others. These compounds are designed to improve immune function and have potential applications in medical treatments.
Career Highlights
Throughout his career, Alexander U Kotov has focused on the development of immunomodulatory compounds. His work has led to the creation of innovative molecules that can significantly impact the field of immunology. With a patent count of 1 patent, he has established himself as a key figure in this area of research.
Collaborations
Kotov has collaborated with notable colleagues, including Alexander A Kolobov and Andrey S Simbirtsev. These partnerships have contributed to the advancement of his research and the development of new immunomodulatory compounds.
Conclusion
Alexander U Kotov is a prominent inventor whose work in immunomodulatory compounds has the potential to transform therapeutic approaches in immunology. His innovative contributions continue to pave the way for future advancements in this critical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile